Research Articles | Page 6 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Transplants in Myelodysplastic Syndromes Dec 2014 Hematol Oncol Clin North Am. myelodysplastic syndromes (MDS)
Transplantation Referral Patterns for Patients with Newly Diagnosed Higher-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia at Academic and Community Sites in the Connect® Myeloid Disease Registry: Potential Barriers to Care Jul 2023 Transplantation and Cellular Therapy myelodysplastic syndromes (MDS)
Transplantation for myelodysplastic syndromes: who, when, and which conditioning regimens Dec 2016 Hematology Am Soc Hematol Educ Program myelodysplastic syndromes (MDS)
Transplantation for myelodysplastic syndromes 2013. Nov 2013 Curr Opin Hematol myelodysplastic syndromes (MDS)
Transplant Referral Patterns for Patients with Newly Diagnosed Higher-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia at Academic and Community Sites in the Connect® Myeloid Disease Registry: Potential Barriers to Care Apr 2023 Transplantation and Cellular Therapy myelodysplastic syndromes (MDS)
Translocation (8;21) acute myeloid leukemia presenting as severe aplastic anemia Jun 2014 Leuk Res Rep aplastic anemia
Transfusion-free interval is associated with improved survival in patients with higher-risk myelodysplastic syndromes engaged in routine care Jun 2018 Leuk Lymphoma myelodysplastic syndromes (MDS)
Transfusion Thresholds, Quality of Life, and Current Approaches in Myelodysplastic Syndromes Apr 2016 Anemia myelodysplastic syndromes (MDS)
Traipsing Through Muddy Waters: A Critical Review of the Myelodysplastic Syndrome/Myeloproliferative Neoplasm (MDS/MPN) Overlap Syndromes Apr 2021 Hematology/oncology clinics of North America myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN)
TP53 mutations in myelodysplastic syndromes and secondary AML confer an immunosuppressive phenotype Jul 2020 Blood acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
Share with addtoany.com.